# Pathos funding rounds and investors

As of 14 Oct 2026, Pathos has raised $365M across 1 verified round on record; latest: $365 million Series D, announced 15 May 2025.

Pathos integrates AI technology, biological modeling, and the largest collection of oncology patient data to make clinical trials smarter and more precise.

Website: https://pathos.com  
Headquarters: Boston  
Page: https://fireround.dev/companies/pathos.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-05-15 | Series D | $365 million | not stated | none named | [fiercebiotech.com](https://www.fiercebiotech.com/biotech/pathos-ai-secures-365m-series-d-fund-trial-novo-nordisk-solid-tumor-drug) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.